Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$919K Hold
15,037
0.63% 67
2017
Q2
$920K Buy
15,037
+3,354
+29% +$204K 0.65% 57
2017
Q1
$708K Hold
11,683
0.43% 77
2016
Q4
$656K Hold
11,683
0.41% 82
2016
Q3
$696K Sell
11,683
-32,619
-74% -$1.91M 0.45% 78
2016
Q2
$2.44M Sell
44,302
-16,331
-27% -$869K 1.15% 17
2016
Q1
$3.06M Sell
60,633
-13,236
-18% -$648K 1.12% 22
2015
Q4
$3.72M Sell
73,869
-58,813
-44% -$2.97M 1.43% 14
2015
Q3
$6.25M Sell
132,682
-25,864
-16% -$1.37M 1.38% 22
2015
Q2
$8.61M Sell
158,546
-838
-0.5% -$47K 1.18% 30
2015
Q1
$8.74M Buy
159,384
+60,889
+62% +$3.45M 1.18% 28
2014
Q4
$5.34M Buy
98,495
+30,579
+45% +$1.7M 1.1% 22
2014
Q3
$3.84M Buy
67,916
+28,296
+71% +$1.59M 0.84% 35
2014
Q2
$2.19M Sell
39,620
-4,105
-9% -$224K 0.47% 66
2014
Q1
$2.37M Hold
43,725
0.54% 62
2013
Q4
$2.09M Sell
43,725
-4,087
-9% -$187K 0.49% 68
2013
Q3
$2.17M Buy
47,812
+7,965
+20% +$364K 0.57% 59
2013
Q2
$1.77M Buy
+39,847
New +$1.78M 0.5% 68

Other funds holding MRK

Quotient Investors's MRK Position: Q3 2017 in Review

Quotient Investors held its Merck (MRK) position steady in Q3 2017 at 15,037 shares worth $919K. The position accounts for 0.63% of the portfolio, ranked #67.

Quotient Investors first reported a position in MRK in Q2 2013 and has held it in 18 quarters since. The position peaked at $8.74M in Q1 2015. 1,924 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Quotient Investors held 15,037 shares of Merck worth $919K as of Q3 2017.
  • Quotient Investors left its Merck share count unchanged in Q3 2017.
  • Merck made up 0.63% of Quotient Investors's portfolio in Q3 2017, its #67 holding.
  • Quotient Investors first reported a position in Merck in Q2 2013 and has held it in 18 quarters since.
  • Quotient Investors's Merck position peaked at $8.74M in Q1 2015.
  • 1,924 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.